Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04638621 · ClinicalTrials.gov registry record
Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study
A clinical trial of Dilated Cardiomyopathy, sponsored by Ohio State University.
- Recruiting
- Registry status
- 650
- Enrollment target
- 1
- Study location
NCT04638621 is a study of Dilated Cardiomyopathy that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 650 participants, above the 155-participant average among 6 other Dilated Cardiomyopathy trials with a reported enrollment target (319% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04638621, a study of Dilated Cardiomyopathy, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- 650 participants
- Enrollment target
- 1
- Study location
Study Summary
The Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Study is an ancillary study from the parent study, DCM Precision Medicine Study. The rationale for the DCM-CMR study is to leverage cardiac magnetic resonance (CMR) imaging to detect earliest findings of DCM in the at-risk family members enrolled into the parent study.
Conditions Studied
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2026-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04638621
The ClinicalTrials.gov registry entry for NCT04638621 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 155-participant average among 6 other Dilated Cardiomyopathy trials with a reported enrollment target (319% higher). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dilated Cardiomyopathy appearing as the primary indexed condition, and to 0 interventions.
NCT04638621 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04638621 about?
NCT04638621 is a clinical study titled "Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Ancillary Study". The Dilated Cardiomyopathy-Cardiac Magnetic Resonance (DCM-CMR) Study is an ancillary study from the parent study, DCM Precision Medicine Study. The rationale for the DCM-CMR study is to leverage cardiac magnetic resonance (CMR) imaging to detect earliest findings of DCM in the at-risk family member...
What is the current status of trial NCT04638621?
This trial is currently recruiting. The enrollment target is 650 participants. The study started on 2021-04-01. Estimated completion is 2026-04.
What conditions does trial NCT04638621 study?
This clinical trial studies the following conditions: Dilated Cardiomyopathy.
Who is sponsoring clinical trial NCT04638621?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04638621 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dilated Cardiomyopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)
RECRUITING · Phase 1
-
Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
RECRUITING · NA
-
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
RECRUITING · NA
-
Pediatric Cardiomyopathy Mutation Analysis
RECRUITING
-
Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy
COMPLETED · Phase 2
-
Nesiritide - Dilated Cardiomyopathy
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.